PS Therapy

PS Therapy is a South Korean biotechnology company dedicated to developing innovative treatments for metabolic and chronic diseases through its proprietary Protein Secretion Technology (PST). The company's platform utilizes viral and non-viral vectors to deliver genetic material that instructs the body's own cells to produce and secrete therapeutic proteins directly into the systemic circulation. This approach aims to address the pharmacokinetic challenges of traditional recombinant protein therapies, such as rapid degradation and the need for frequent injections. PS Therapy's lead programs focus on GDF15-based therapies for the treatment of obesity and cancer-related cachexia. By transforming the liver into a sustainable 'bio-factory,' the company seeks to provide long-term efficacy with improved patient compliance.